In a time when COAs are more nuanced, critical and complex than ever, researchers can turn to best practices to move forward ...

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

Using patient-reported outcomes (PROs) provides important insights from the patient's perspective and can be valuable to monitor and manage treatment-related adverse events during cancer treatment.

Their shared dedication reflects a broader mission to bring meaningful change to women’s health, offering hope and tangible ...

Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most ...

Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and ...